🇺🇸 Levotuss in United States
65 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 65
Most-reported reactions
- Pneumonia — 13 reports (20%)
- Nausea — 9 reports (13.85%)
- Dyspnoea — 8 reports (12.31%)
- Erythema — 6 reports (9.23%)
- Eyelid Oedema — 6 reports (9.23%)
- Dizziness — 5 reports (7.69%)
- Febrile Neutropenia — 5 reports (7.69%)
- Thrombocytopenia — 5 reports (7.69%)
- Acute Kidney Injury — 4 reports (6.15%)
- Aspartate Aminotransferase Increased — 4 reports (6.15%)
Other Other approved in United States
Frequently asked questions
Is Levotuss approved in United States?
Levotuss does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Levotuss in United States?
Hyundai Pharm is the originator. The local marketing authorisation holder may differ — check the official source linked above.